신일제약

012790KOSDAQ

61.0 / 100

Reference Date: 2026-09-08

Financial Score26.5 / 40

News Sentiment12.5 / 25

Momentum12.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but Operating Profit is on a declining trend. Rose 9.7% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Shinil Pharmaceutical, established in 1971, specializes in the production and sale of various pharmaceuticals such as tablets, capsules, and ointments, while also operating a CDMO business. The company diversifies its operations through the 'Pamtree' brand, offering functional cosmetics and health supplements, alongside revenue from medical devices and real estate rentals.

Number of Employees

413people

Average Salary

49.9M KRW

Score Calculation Basis

Detailed Financial Score

PER

9.25Industry Average 15.006.5Point

Lower than industry avg (good)

PBR

0.47Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE

5.04Industry Average 8.002.5Point

Below industry avg

Debt Ratio

1.62Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20252.5 / 10 points

Revenue Growth Rate

0.5 / 3

Avg ▼4.8% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼21.3% (2-year basis)

ROE Trend

2.0 / 4

Avg ROE 8.6% (declining, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position6.0Point

52w upper range (70%)

Current 6,020Won52-week high 6,48052-week low 4,900

1-month return5.0Point

1m +9.65% (rising)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral반기보고서 (2026.06)2026-08-14